Correlates of Increased Chemerin but Reduced Oxytocin with Adiposity and Atherogenecity Indices in Metabolic Syndrome Patients.Published in:Jordan Journal of Pharmaceutical Sciences, 2019, v. 12, n. 2, p. 125By:Al-Neimat, Oneassa S.;Kasabri, Violet;Naffa, Randa;Akour, Amal;Abu Jbara, Mousa;Bustanji, YasserPublication type:Article